Login with your work email address to view charts. No credit card required.
| Art Unit: | 1615 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 435 — Chemistry: molecular biology and microbiology 504 — Plant protecting and regulating compositions |
| Phone: | (571) 272-0138 |
| Email: | None |
| Location: | None |
| Title: | Pat Examnr Physics |
| Service: | 2 years |
| Grade: | GS-09 |
Below is the grant rate timeline for Examiner Rossi, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Rossi's grant rate is lower than that of Art Unit 1615 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Rossi | 0.9 |
| Art Unit 1615 | 1.8 |
Examiner Rossi has granted 0 of 6 cases without any applicant-requested interviews for a grant rate of 0%.
Examiner Rossi has granted 0 of 0 cases with at least one applicant-requested interview for a grant rate of 0%.
With Examiner Rossi, conducting an interview increases your chance of getting a patent granted by 100%.
| Number | Title | OA Rejections | Status | IFW |
|---|---|---|---|---|
| 17772985 | Compositions And Methods For Prophylaxis Of Hiv | Rejection information available with a Premium Stats subscription. See our pricing. | Abandoned | View |
| 17921158 | Methods And Compositions Relating To Ionic Liquid Adjuvants | Abandoned | View | |
| 17627698 | Method For Decreasing Adverse-Effects Of Interferon | Abandoned | View | |
| 18007701 | Kappa Opioid Receptor Agonist-Therapeutic Antigen Binding Protein Conjugate (Ktac) Compounds | Abandoned | View | |
| 18011647 | Cell Lines Secreting Alpha-Synuclein Targeting Antibodies, Progranulin And Prosaposin And A Complex Of Both, And Gdnf | Abandoned | View | |
| 17778394 | Method For Extracting A Protein From A Precipitate And Method For Precipitating Impurities | Patented | View | |
| 17544522 | Lewis Y Radioimmunotherapy For The Treatment Of Cancer | Patented | View | |
| 17917421 | Immunogenic Composition Comprising An Antigenic Moiety And A Liposomal Formulation, Method Of Producing The Composition, The Composition For Use As A Medicament, In Particular For Use As A Vaccine | Abandoned | View | |
| 17917433 | Compositions And Methods For Vaccination And The Treatment Of Infectious Diseases | Abandoned | View | |
| 17914734 | T-Cell Modulatory Multimeric Polypeptides With Conjugation Sites And Methods Of Use Thereof | Abandoned | View | |
| 17726486 | Preservative For In Vitro Diagnostic Reagent And Use Thereof | Abandoned | View | |
| 17177236 | Method For Protein Purification | Patented | View | |
| 18054244 | Prevention Of Visible Particle Formation In Parenteral Protein Solutions | Abandoned | View | |
| 18181437 | Masp-2 And Masp-3 Inhibitors, And Related Compositions And Methods, For Treatment Of Sickle Cell Disease | Abandoned | View | |
| 17762854 | Fusion Polypeptides Binding Antibody Fc Domains And Integrin And Methods Of Use | Patented | View | |
| 17633893 | Use Of The Anti-P-Selectin Antibody Crizanlizumab For Treating Sickle Cell Nephropathy And Chronic Kidney Disease Associated With Sickle Cell Disease | Abandoned | View | |
| 17808319 | Antibodies Against Lif And Uses Thereof | Abandoned | View | |
| 17917418 | Frb Antibodies | Patented | View | |
| 18132052 | High Affinity Il-2 Receptor Agonists And Immunosuppressants To Enhance Immune Tolerance | Abandoned | View | |
| 17607879 | Anti-Galectin-9 Antibodies And Uses Thereof | Abandoned | View | |
| 17604928 | Chemically Induced Protein Dimerization Systems | Patented | View | |
| 17634405 | Therapeutic Peptides | Abandoned | View | |
| 18113413 | Immune Antigen Specific Il-18 Immunocytokines And Uses Thereof | Patented | View | |
| 17625693 | Anti-Serine Protease Inhibitor Kazal (Spik) Antibodies, Immunoconjugates, And Methods Of Use | Patented | View | |
| 18118971 | Immunosuppressant In Combination With High Affinity Il-2 Receptor Agonists And Related Dosing | Abandoned | View |
Subscribe to Premium Examiner Statistics for unlimited access for your law firm.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.